The anti-bacterial coatings market for medical implants was valued at $234.42 million in 2020, and is estimated to reach $1,072.27 million by 2030, growing at a CAGR of 16.4% from 2021 to 2030. Anti-bacterial coatings are materials that reduce implants-related infections in patients by inhibiting bacterial adhesion, colonization, and proliferation of bacteria on the implant surface and into the surrounding tissues. Medical implants are highly susceptible to infection and may result to risk in surgery. Therefore, treatment with anti-bacterial coatings provide protection against pathologically relevant strains of bacteria.
Growth of the anti-bacterial coatings market for medical implants is majorly driven by alarming rise in prevalence of implant associated infections, technological advancements in anti-bacterial coatings, and high adoption of cardiovascular & orthopedics implants. Moreover, increase in geriatric population and rise in burden of bone related disorders and cardiovascular diseases across the globe further drives the market growth. In addition, the U.S. has one of the most robust healthcare system globally. There has been surge in healthcare investment in the country, owing to the COVID-19 outbreak. The preference for anti-bacterial coated medical equipment in the U.S. is increasing due to the various initiatives taken by the government as well as the hospitals in the country to prevent nosocomial infection. These aforementioned factors contribute towards the growth of the market. Conversely, increase in awareness about implantation surgeries, development of effective anti-bacterial coating for medical implants, and rise in demand for better healthcare facilities are expected to provide opportunities for the market growth during the forecast period. However, high cost of implantation procedures and raw materials involved in the manufacturing of coatings restricts the market growth.
Moreover, key players such as Hydromer Inc., Covalon Technologies Ltd., and AST Product, provide numerous anti-bacterial coatings products to contribute toward the market growth.
Cardiovascular diseases (CVDs) are the leading cause of death across the globe, with an estimate of 17.9 million fatalities each year. According to report of the British Heart Foundation, in 2021, 7.6 million people were diagnosed with heart & circulatory diseases, causing about 25% death in UK. Thus, rise in use of anti-bacterial coatings in cardiac implants products, which are used during cardiac surgeries, contributes toward the growth of anti-bacterial coatings market.
The anti-bacterial coating market for medical implants is segmented on the basis of material, product type, and region. By material, it is bifurcated into metallic and non-metallic coatings. Metallic coatings are further segmented into silver coatings, copper coatings, and other coatings. Non-metallic coatings segment is further divided into polymeric coatings and organic coatings. On the basis of type, the market is divided into orthopedic, dental, neurovascular, cardiac, and other implants. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global anti-bacterial coatings market are Aap Implantate AG, AST Products, Inc., BioCote Ltd., Covalon Technologies Ltd., DOT GmbH, Harland Medical Systems Inc., Hydromer, Inc., Secoa Metal Finishing, Sciessent LLC, and Specialty Coating Systems, Inc.
Growth of the anti-bacterial coatings market for medical implants is majorly driven by alarming rise in prevalence of implant associated infections, technological advancements in anti-bacterial coatings, and high adoption of cardiovascular & orthopedics implants. Moreover, increase in geriatric population and rise in burden of bone related disorders and cardiovascular diseases across the globe further drives the market growth. In addition, the U.S. has one of the most robust healthcare system globally. There has been surge in healthcare investment in the country, owing to the COVID-19 outbreak. The preference for anti-bacterial coated medical equipment in the U.S. is increasing due to the various initiatives taken by the government as well as the hospitals in the country to prevent nosocomial infection. These aforementioned factors contribute towards the growth of the market. Conversely, increase in awareness about implantation surgeries, development of effective anti-bacterial coating for medical implants, and rise in demand for better healthcare facilities are expected to provide opportunities for the market growth during the forecast period. However, high cost of implantation procedures and raw materials involved in the manufacturing of coatings restricts the market growth.
Moreover, key players such as Hydromer Inc., Covalon Technologies Ltd., and AST Product, provide numerous anti-bacterial coatings products to contribute toward the market growth.
Cardiovascular diseases (CVDs) are the leading cause of death across the globe, with an estimate of 17.9 million fatalities each year. According to report of the British Heart Foundation, in 2021, 7.6 million people were diagnosed with heart & circulatory diseases, causing about 25% death in UK. Thus, rise in use of anti-bacterial coatings in cardiac implants products, which are used during cardiac surgeries, contributes toward the growth of anti-bacterial coatings market.
The anti-bacterial coating market for medical implants is segmented on the basis of material, product type, and region. By material, it is bifurcated into metallic and non-metallic coatings. Metallic coatings are further segmented into silver coatings, copper coatings, and other coatings. Non-metallic coatings segment is further divided into polymeric coatings and organic coatings. On the basis of type, the market is divided into orthopedic, dental, neurovascular, cardiac, and other implants. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global anti-bacterial coatings market are Aap Implantate AG, AST Products, Inc., BioCote Ltd., Covalon Technologies Ltd., DOT GmbH, Harland Medical Systems Inc., Hydromer, Inc., Secoa Metal Finishing, Sciessent LLC, and Specialty Coating Systems, Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the antibacterial coatings market analysis from 2020 to 2030 to identify the prevailing antibacterial coatings market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the antibacterial coatings market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global antibacterial coatings market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Material
- Metallic Coatings
- Non-Metallic Coatings
By Type
- Cardiac Implants
- Orthopedic Implants
- Dental Implants
- Neurological Implants
- Other Implants
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- AAP IMPLANTATE AG
- AST PRODUCTS INC.
- BIOCOTE LTD.
- COVALON TECHNOLOGIES, LTD.
- DOT GMBH
- HARLAND MEDICAL SYSTEMS, INC.
- HYDROMER INC.
- SCIESSENT LLC.
- SPECIALTY COATING SYSTEMS, INC.
- Secoa Technology
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ANTIBACTERIAL COATINGS MARKET, BY MATERIAL
CHAPTER 5: ANTIBACTERIAL COATINGS MARKET, BY TYPE
CHAPTER 6: ANTIBACTERIAL COATINGS MARKET, BY REGION
CHAPTER 7: COMPANY LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Antibacterial Coatings Market for Medical Implants,' the antibacterial coatings market was valued at $234.42 million in 2020, and is estimated to reach $1.1 billion by 2030, growing at a CAGR of 16.4% from 2021 to 2030.Antibacterial coatings are materials that prevent the bacterial adhesion and biofilm formation on the surface of medical implants. In addition, they act as anti-thrombotic coating, which prevents the formation of thrombus during bacterial infections after the surgery in patient. So accordingly, medical implants are coated with antibacterial coating to obtain an ideal potent surface that can provide protection against the pathogens.
Factors that drive the growth of the global antibacterial coatings market size include, increase in number of cardiac surgeries, which increases the usage of cardiac implants products. Furthermore, rise in prevalence of implant associated infections, which are related to prosthetic joints and internal fixation devices or implants where the bacteria adhere to the implant’s surface and forms the biofilm. These biofilms are not only resistant to phagocytosis, but also to most antimicrobial agents. Therefore, they cause various bacterial infections that affect both implants and neighboring tissues. However, to eliminate the occurrence of bacterial biofilm, the implants are coated with antibacterial agents, such as metal nanoparticles, antibiotics, polymers, and other antimicrobial agents. This coating keeps away the foreign material to accumulate on the implant surface. Moreover, implant manufacturers themselves are adopting measures to improve the safety of devices by incorporating appropriate medical coatings, thereby supplementing the market growth.
Moreover, development of pharmaceutical and medical device industries and improvement in healthcare spending are anticipated to drive the growth of the antibacterial coatings industry. In addition, increase in demand for performing dental implants led to development of anti-microbial coatings materials in the healthcare sector, thereby propelling growth of the market.
Moreover, initiatives taken by governments for development of coatings materials and by the healthcare sector for manufacturing of anti-bacterial coatings materials are the key factors that boost the growth of the market. Furthermore, surge in geriatric population, who are more vulnerable to cardiovascular disease led to increase in number of cardiac implant surgeries and rise in usage of cardiac implants products increase the production of anti-bacterial coatings propel the growth of the market.
As per the American Academy for Implant Dentistry, over 15 million people in the U.S. undergo bridge and crown replacements for missing teeth every year. Thus, facilitating the demand for dental implants, which increases the use of anti-bacterial coatings. Thus, driving the growth of the market. In addition, rise in number of cardiovascular diseases results in increase in number of cardiac implant procedures. This has led to increase in usage of anti-bacterial coatings that boosts the growth of the market. Geriatric population is at high risk of suffering from cardiovascular diseases, increasing the demand for surgical interventions. Thus, rise in geriatric population is expected to drive the antibacterial coatings market growth during forecast period.
The anti-bacterial coatings market is segmented on the basis of materials, product type, and region. On the basis of material, the market is segmented into metallic coatings and non-metallic coatings. Metallic coatings segment dominated the growth of the market in 2020. This is attributed to the usage applicability and availability of metallic coatings in medical & clinical settings. On the basis of product type, the market is divided into orthopedic implants, dental implants, neurovascular implants and others implants includes bone graft substitutes and craniomaxillofacial implants. The other implants segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in number of bone graft substitutes and craniomaxillofacial implants surgeries and advancements in R&D activities in pharmaceutical and medical device industries.
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region-wise, North America accounted for a majority of the antibacterial coatings market share in 2020, and is anticipated to remain dominant during the antibacterial coatings market forecast. This is attributed to rise in prevalence of cardiovascular disorders and dental disorders, increase in number of approvals for anti-bacterial coatings material, and presence of key players. Asia-Pacific is anticipated to witness lucrative growth during antibacterial coatings market analysis, owing to increase in number of orthopedic implant surgeries, rise in number of geriatric populations, and growth in healthcare expenditures.
KEY FINDINGS OF THE STUDY
- By material, the metallic coatings segment was the highest contributor to the market in 2020.
- On the basis of type, the other implants segment dominated the antibacterial coatings industry in 2020, and is expected to continue this trend during the forecast period.
- Region-wise, North America accounted for a majority of the anti-microbial coatings market share in 2020, and is anticipated to remain dominant during the forecast period.
Companies Mentioned
- AAP IMPLANTATE AG
- AST PRODUCTS INC.
- BIOCOTE LTD.
- COVALON TECHNOLOGIES, LTD.
- DOT GMBH
- HARLAND MEDICAL SYSTEMS, INC.
- HYDROMER INC.
- SCIESSENT LLC.
- SPECIALTY COATING SYSTEMS, INC.
- Secoa Technology
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 161 |
| Published | May 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 234.42 million |
| Forecasted Market Value ( USD | $ 1072.27 million |
| Compound Annual Growth Rate | 16.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
